23.44USDMkt Cap: 151.47M USDP/E: —Last update: 2026-05-22
Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate t…
Industry Peers
Drug Manufacturers - Specialty & Generic153.28BSEKP/E 169.8
56.23BTRYP/E 26.9
55.91BEURP/E 22.1
33.39BPLNP/E 21.7
13.24BSEKP/E 39.9
13.20BEURP/E 30.1
12.83BTRY—
3.96BUSDP/E 33.6
loading…
Indicators:|
Key Statistics
Company
Market Cap151.47M USD
Enterprise Value119.77M USD
Revenue (TTM)102.16M USD
Gross Profit83.33M USD
Net Income (TTM)-30.38M USD
Revenue/Share15.92 USD
Last Price23.44 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees53
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINLU1953136287
Valuation
P/E (Trailing)—
P/E (Forward)9.06
PEG0.89
EV/EBITDA31.30
EV/Revenue1.17
P/S1.48
P/B1.99
EPS (TTM)-5.55
EPS (Forward)2.58
52W Range
23.3886% of range23.45
52W High23.45 USD
52W Low23.38 USD
Profitability
Gross Margin70.19%
Oper. Margin-185.95%
EBITDA Margin3.75%
Profit Margin-25.59%
ROE-32.33%
ROA-11.38%
Growth
Revenue Growth-62.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.18M USD
CapEx (TTM)—
FCF Margin7.59%
FCF Yield5.12%
Net Debt-31.26M USD
Net Debt/EBITDA-8.17
Balance Sheet
Debt/Equity0.43
Current Ratio1.82
Quick Ratio1.45
Book Value/Sh11.73 USD
Cash/Share11.07 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateDec 26, 2025
Analyst Consensus
Rating2.5 (Hold)
Target (Mean)24.43 USD
Target Range21.80 USD – 28.00 USD
# Analysts3
Ownership
Shares Out.6.46M
Float5.63M
Insiders1.97%
Institutions39.94%
Short Interest
Short Ratio1.1d
Short % Float4.55%
Short % Out.4.49%
Shares Short289.28K
Short (prev mo.)301.84K
Technical
SMA 5018.71 (+25.3%)
SMA 20013.51 (+73.5%)
Beta0.45
S&P 52W Chg28.31%
Avg Vol (30d)284.40K
Avg Vol (10d)423.74K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—